Every dated change on the records linked to Adult T-cell leukaemia/lymphoma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Confirmed overall response 11 per cent with mogamulizumab against 0 per cent with chemotherapy; progression-free survival hazard ratio 0.
The revised report added the classification of cutaneous disease, disease in the central nervous system, the management of older and transplant-ineligible patients, upfront allogeneic transplant and newer agents, and stated that a best practice approach was adopted because the clinical evidence was of lower quality.
Relapsed CCR4+ adult T-cell leukaemia/lymphoma; later PTCL/CTCL
Overall response 50 per cent (13 of 26), eight complete; median progression-free survival 5.
The subclassification proposed by Shimoyama and adopted by the international consensus meetings divides the disease into acute, lymphoma, chronic and smouldering types, using the count of circulating tumour cells, the lactate dehydrogenase, the calcium and the sites involved. It is the first decision and it changes everything: the chronic and smouldering types without unfavourable features are watched, while the acute and lymphoma types are treated at once. The consensus report sets out prognostic factors and a set of response criteria specific to this disease, which is why trials in it are not reported like trials in other lymphomas.
Three things that belong to this disease and not to the rest of the family. Calcium, which can be very high because the tumour makes parathyroid hormone-related protein, and which may present as confusion, thirst or kidney failure before the lymphoma is recognised. Strongyloides stercoralis, because corticosteroids can precipitate fulminant infection with this worm: the 2009 consensus report says testing is warranted before they are used in people from endemic areas, and that preventive ivermectin or albendazole should be considered in anyone exposed to the parasite in the tropics. And the central nervous system, which is commonly involved in the aggressive types and is examined by lumbar puncture.
The consensus meeting set out the acute, lymphoma, chronic and smouldering types, the prognostic factors and a set of response criteria specific to the disease, which became the standard reference for trials.